Bank Of New York Mellon Corp Sarepta Therapeutics, Inc. Transaction History

Bank Of New York Mellon Corp

$541 Trillion
Q4 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$100.86 - $132.13 $201 Million - $263 Million	1,993,833 New	1,993,833 $258 Million
Q3 2022 Nov 14, 2022	SELL	$75.71 - $119.24 $8.17 Million - $12.9 Million	-107,929 Reduced 5.42%	1,882,998 $208 Million
Q2 2022 Aug 15, 2022	BUY	$62.69 - $88.44 $1.01 Million - $1.42 Million	16,104 Added 0.82%	1,990,927 $149 Million
Q1 2022 May 11, 2022	SELL	$63.15 - $90.42 $2.08 Million - $2.98 Million	-32,912 Reduced 1.64%	1,974,823 $154 Million
Q4 2021 Feb 11, 2022	BUY	$77.28 - $99.42 $3.85 Million - $4.95 Million	49,770 Added 2.54%	2,007,735 $181 Million
Q3 2021 Nov 12, 2021	SELL	$65.97 - $92.48 $1.51 Million - $2.11 Million	-22,824 Reduced 1.15%	1,957,965 $181 Million
Q2 2021 Aug 11, 2021	BUY	$69.38 - $86.75 $13.1 Million - $16.4 Million	189,495 Added 10.58%	1,980,789 $154 Million
Q1 2021 May 13, 2021	BUY	$72.25 - $168.95 $36.6 Million - $85.7 Million	507,151 Added 39.49%	1,791,294 $134 Million
Q4 2020 Feb 09, 2021	BUY	$125.56 - $178.74 $1.61 Million - $2.29 Million	12,811 Added 1.01%	1,284,143 $219 Million
Q3 2020 Nov 12, 2020	SELL	$127.12 - $172.34 $3.16 Million - $4.28 Million	-24,833 Reduced 1.92%	1,271,332 $179 Million
Q2 2020 Aug 12, 2020	BUY	$93.0 - $171.7 $14.9 Million - $27.4 Million	159,776 Added 14.06%	1,296,165 $208 Million
Q1 2020 May 06, 2020	SELL	$82.38 - $131.64 $1.47 Million - $2.34 Million	-17,792 Reduced 1.54%	1,136,389 $111 Million
Q4 2019 Feb 14, 2020	SELL	$76.53 - $135.58 $2.56 Million - $4.53 Million	-33,444 Reduced 2.82%	1,154,181 $149 Million
Q3 2019 Nov 07, 2019	BUY	$72.81 - $156.91 $16.1 Million - $34.8 Million	221,636 Added 22.94%	1,187,625 $89.5 Million
Q2 2019 Aug 12, 2019	BUY	$112.21 - $151.95 $12.3 Million - $16.7 Million	109,743 Added 12.82%	965,989 $147 Million
Q1 2019 May 14, 2019	BUY	$106.67 - $151.68 $30.5 Million - $43.3 Million	285,578 Added 50.04%	856,246 $102 Million
Q4 2018 Feb 11, 2019	BUY	$97.32 - $148.76 $28.4 Million - $43.4 Million	291,823 Added 104.65%	570,668 $62.3 Million
Q3 2018 Nov 09, 2018	BUY	$115.31 - $161.51 $407,851 - $571,260	3,537 Added 1.28%	278,845 $0
Q2 2018 Aug 06, 2018	SELL	$71.74 - $153.69 $3.02 Million - $6.46 Million	-42,033 Reduced 13.25%	275,308 $36.4 Million
Q1 2018 May 15, 2018	SELL	$54.02 - $82.27 $24,038 - $36,610	-445 Reduced 0.14%	317,341 $23.5 Million
Q4 2017 Feb 09, 2018	BUY	$47.64 - $56.75 $15.1 Million - $18 Million	317,786	317,786 $17.7 Million

Others Institutions Holding SRPT

# of Institutions

535

Shares Held

87.4M

Call Options Held

1.55M

Put Options Held

1.35M

Black Rock Inc. New York, NY

10.3M
Shares

$765 Million
0.04% of portfolio
Vanguard Group Inc Valley Forge, PA

9.09M
Shares

$673 Million
0.02% of portfolio
Capital International Investors Los Angeles, CA

8.7M
Shares

$644 Million
0.21% of portfolio
Janus Henderson Group PLC London, X0

4.33M
Shares

$321 Million
0.28% of portfolio
State Street Corp Boston, MA

4.07M
Shares

$302 Million
0.02% of portfolio

View Full List

About Sarepta Therapeutics, Inc.

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $6.49B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

More about SRPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Account